Keyphrases
Drug-induced Arrhythmia
100%
Obstructive Pulmonary Disease
100%
Chronic Obstructive Pulmonary Disease
87%
Asthma
62%
Drug Label
62%
Ventricular Arrhythmia
62%
Resting Heart Rate
37%
Inconsistency
25%
Separation Analysis
25%
Sudden Cardiac Death
25%
Clinical Significance
12%
Healthcare Professionals
12%
All-cause Mortality
12%
Product-specific
12%
Preventive Measures
12%
General Practitioners
12%
Pharmacological Therapy
12%
Cardiac Patients
12%
Haloperidol
12%
Mortality in Elderly
12%
Chronic Obstructive Pulmonary Disease Patient
12%
Electrocardiographic Monitoring
12%
Daily Clinical Practice
12%
Risk Minimization
12%
Cardiovascular Disease
12%
Elderly Patients
12%
Heart Failure Patients
12%
Pulmonary Care
12%
Non-fatal
12%
Tachycardia
12%
Pulmonary Complications
12%
Patient Selection
12%
Survival Rate
12%
Background Risk
12%
Electrocardiographic Abnormalities
12%
Cardiovascular Care
12%
Routine Care
12%
QT-prolonging Drugs
12%
Independent Risk Factors
12%
QT Prolongation
12%
Drug Labeling
12%
Arrhythmia
12%
Behavioral Counseling
12%
QT Interval
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Heart Arrhythmia
100%
Diseases
100%
Asthma
31%
Sudden Cardiac Death
12%
Pharmacotherapy
6%
Drug Labeling
6%
Cholinergic Receptor Blocking Agent
6%
All Cause Mortality
6%
Tachycardia
6%
QT Prolongation
6%
Survival Rate
6%
ECG Abnormality
6%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
6%
Cardiovascular Disease
6%